Israel Englander Sera Prognostics, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.6 - $11.69 $1.26 Million - $2.62 Million	-224,550 Reduced 77.58%	64,906 $384,000
Q1 2024 May 15, 2024	BUY	$5.05 - $10.0 $1.46 Million - $2.89 Million	289,456 New	289,456 $2.63 Million
Q4 2022 Feb 14, 2023	SELL	$1.16 - $1.8 $13,906 - $21,578	-11,988 Reduced 41.46%	16,929 $21,000
Q3 2022 Nov 14, 2022	SELL	$1.55 - $2.71 $67,099 - $117,315	-43,290 Reduced 59.95%	28,917 $46,000

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $257M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.